Slide 1: Wockhardt Limited Investor Presentation
Wockhardt Limited Investor Presentation By Dr. Murtaza Khorakiwala Managing Director Q1FY16
Slide 2: Safe Harbor Statement
Safe Harbor Statement • Except for historical information contained herein, statements in this communication, which include words or phrases such as “will”, “aim”, “will likely result”, “would”, “believe”, “August”, “expect”, “will continue”, “anticipate”, “estimate”, “intend”, “plan”, “contemplate”
Slide 3: Introduction to Wockhardt
Introduction to Wockhardt Key Business Dynamics
Slide 4: Wockhardt Today
Wockhardt Today UK, Ireland, France, Switz. USA Direct Operations in India, USA Mexico India and Europe Multi Ethnic workforce from 21 different Nationalities Wockhardt Direct ROW operations operations Investor Presentation August 2015 4
Slide 5: Wockhardt Today
Wockhardt Today UK Ireland 9 sites Chicago in India 12 Baddi Manufacturing Locations globally Ankleshwar Daman (2 Plants) Aurangabad (5 Plants) Formulations APIs Investor Presentation August 2015 5
Slide 6: Wockhardt Today R&D Centers
Wockhardt Today 3 R&D Centers worldwide USA / UK & India Investor Presentation August 2015 6
Slide 7: Key Business Update
Key Business Update Fvocknakor \Ykks
Slide 8: Key Business Update
Key Business Update Regulatory Update US FDA has completed inspection in one of the manufacturing facility in Himachal Pradesh in July, 2015 and no 483 has been issued to the company. US FDA’s inspection of Waluj facility completed during the quarter with minor observations. The Company’s on g
Slide 9: Q1FY16 Results
Q1FY16 Results Fvocknakor \Ykks
Slide 10: Sales – Growth of 15% over Q1FY15
Sales – Growth of 15% over Q1FY15 Rs.crore Growth of 15% in Q1FY16 over Q1FY15 Investor Presentation August 2015 10
Slide 11: EBITDA – Growth of 165% over Q1FY15
EBITDA – Growth of 165% over Q1FY15 Rs.crore Growth of 165% in Q1FY16 over Q1FY15 Investor Presentation August 2015 11
Slide 12: PAT – Growth of 470% over Q1FY15
PAT – Growth of 470% over Q1FY15 Rs.crore Growth of 470% in Q1FY16 over Q1FY15 Investor Presentation August 2015 12
Slide 13: Research – 13.3% of Sales in Q1FY16
Research – 13.3% of Sales in Q1FY16 Growth of 31% in Q1FY16 over Q1FY15 Investor Presentation August 2015 13
Slide 14: US Business
US Business • Contributes 20% of Total Revenue. • Declines by 21% (26% in $ terms) 400 USA over Q1FY15. $48 • During the Q1FY16, 5 ANDA’s filed $36 200 & 1 approval received cumulative Rs.cr. ANDA’s pending for approval is 73. 287 227 - Q1-FY15 Q1-FY16 Investor Presentation August 2015 14
Slide 15: EU Operations
EU Operations UK UK Operations 420 370 £ 37 • 1 New filing done and 1 New product launched in 320 Q1FY16. • UK operation Grows by 55% (grows by 59% £ terms) in Rs.cr. 270 £ 23 220 Q1FY16. 170 237 368 120 Q1-FY15 Q1-FY16 €5 Ireland 44 43 42 Ireland Operations 41 • Ireland Declines by 11% (growth of 4
Slide 16: India & Emerging Markets
India & Emerging Markets • India Business Grows by 27% for Q1FY16. • 24 new products in Q1FY16 launched in India. • Emerging Market operations grew by 47% in Q1FY16. 500 India & Emerging Markets (EM) 97 400 EM 66 300 EM Rs.cr. 200 375 295 India 100 India 0 Q1FY15 Q1FY16 Investor Presentation August
Slide 17: For investor updates and communication please visit www.wockhardt.com
For investor updates and communication please visit www.wockhardt.com For Information please contact Arun Khatanhar Tel.: +91 22 71596228 Akhatanhar@wockhardt.com 17 Investor Presentation August 2015